Ischemic heart disease is a common consequence of coronary artery disease (CAD), which is primarily driven by atherosclerosis, a chronic inflammatory ...
Researchers have unveiled a novel immune mechanism by which tandem kinases combat pathogen invasion: an atypical NLR protein, ...
AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
FDA meeting to align on myositis registrational trial designs for rese-cel in 1H25 on track –– Enrolling approximately one patient per week ...
Researchers at the University of Cologne have found that mRNA-based COVID-19 vaccines have a lasting impact on the innate ...
Researchers at the University of Calgary have uncovered biological differences between the sexes in how chronic pain is ...
A clinical trial shows that a specific probiotic blend reduced fever duration by 48 hours in children with respiratory ...
A discovery published in Nature Immunology has shed light on why the immune system is less aggressive toward self-antigens, ...
Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.
Researchers from the La Jolla Institute for Immunology recently used the Expanse supercomputer at the San Diego Supercomputer ...
Treatment with VXM01, an investigational vaccine, plus Bavencio demonstrated both safety and tolerability in patients with ...
Scientists used advanced data analysis and machine learning to identify the viral proteins that may trigger autoimmune disorders such as type 1 diabetes and rheumatoid arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback